2002 | Maureen P. Martin, Xiaojiang Gao, Jeong-Hee Lee, George W. Nelson, Roger Detels, James J. Goedert, Susan Buchbinder, Keith Hoots, David Vlahov, John Trowsdale, Michael Wilson, Stephen J. O'Brien & Mary Carrington
The study by Martin et al. (2002) investigates the epistatic interaction between the KIR3DS1 allele and HLA-B Bw4-80Ile alleles in delaying the progression to AIDS in individuals infected with HIV-1. The authors found that the combination of KIR3DS1 and HLA-B Bw4-80Ile is strongly protective against AIDS progression, while the presence of either allele alone does not show significant effects. Specifically, the HLA-B Bw4-80Ile allele alone is associated with delayed progression, but in the absence of KIR3DS1, it does not influence AIDS outcomes. Conversely, the absence of HLA-B Bw4-80Ile alleles leads to more rapid progression in the presence of KIR3DS1. This suggests a synergistic effect between the two loci, with KIR3DS1 binding to HLA-B Bw4-80Ile molecules, activating NK cells and potentially T cells, and leading to the elimination of HIV-1-infected cells. The protective effect of KIR3DS1 + HLA-B Bw4-80Ile is dominant over the susceptibility conferred by KIR3DS1 homozygosity. The study highlights the importance of this genetic interaction in the early innate immune response to HIV-1 infection and its potential implications for therapeutic and vaccine development.The study by Martin et al. (2002) investigates the epistatic interaction between the KIR3DS1 allele and HLA-B Bw4-80Ile alleles in delaying the progression to AIDS in individuals infected with HIV-1. The authors found that the combination of KIR3DS1 and HLA-B Bw4-80Ile is strongly protective against AIDS progression, while the presence of either allele alone does not show significant effects. Specifically, the HLA-B Bw4-80Ile allele alone is associated with delayed progression, but in the absence of KIR3DS1, it does not influence AIDS outcomes. Conversely, the absence of HLA-B Bw4-80Ile alleles leads to more rapid progression in the presence of KIR3DS1. This suggests a synergistic effect between the two loci, with KIR3DS1 binding to HLA-B Bw4-80Ile molecules, activating NK cells and potentially T cells, and leading to the elimination of HIV-1-infected cells. The protective effect of KIR3DS1 + HLA-B Bw4-80Ile is dominant over the susceptibility conferred by KIR3DS1 homozygosity. The study highlights the importance of this genetic interaction in the early innate immune response to HIV-1 infection and its potential implications for therapeutic and vaccine development.